Denali Therapeutics Inc.
Compounds, Compositions and Methods

Last updated:

Abstract:

The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Status:
Application
Type:

Utility

Filling date:

5 Feb 2020

Issue date:

8 Oct 2020